This inventor holds 1 USPTO granted patent. Top assignee: Muscagen Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Robin Havard Davies
Introduction
Robin Havard Davies is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of adenosine analogue-type A3 receptor agonists. His work has implications for various therapeutic applications.
Latest Patents
Robin Havard Davies holds 1 patent related to his innovative research. The patent focuses on adenosine analogue-type A3 receptor agonists characterized by a specific formula. This formula includes components where D is N or CH, E is O, and X is a group of the formula —CRR-CYCLE.
Career Highlights
Currently, Robin is associated with Muscagen Limited, where he continues to advance his research and development efforts. His expertise in pharmacology and receptor biology has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Robin has collaborated with esteemed colleagues, including Luis Garcia Sevillano and Christopher McGuigan. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Robin Havard Davies exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile